Criticality of functional excipients and decoding methods during generic product development

Pharmaceutical Technology Europe

Volumn 18, Issue 6, 2006, Pages 34-38

  Bansal, Arvind K ^a   Mulla, Mudassar ^a   Kakumanu, Vasu Kumar ^a  

^a NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELCOX; CELECOXIB; CROSCARMELLOSE SODIUM; DODECYL SULFATE SODIUM; LACTOSE; MAGNESIUM STEARATE; SODIUM HYDROXIDE;

ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG CAPSULE; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 33745194596     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. D.M. Kirking, J. Amer. Pharm. Assoc. 41(4) 517-518 (2001).
2. A.C. Jones, Scrip 123 13-15 (2003).
3. C.P. Milne and C. Cairns, Pharm. Dev. Regulations 1(1) 11-17 (2003).
4. Anon, Scrip Daily (March), 1-3 (2004).
5. J.M. Peny, Scrip 122 13-17 (2003).
6. W.F. Jakob and Y.H. Kwak, Technovation 23(4), 291-296 (2003).
7. J.A. Cook and H.N. Bockbrader, Disso. Technol. 9(2) 25-27 (2002).
8. A.K. Bansal and V. Koradia, Pharm. Tech. 29(8), 50-55 (2005).
9. www.rxlist.com/top200_sales_2004.htm (Accessed on Sept 2005).
10. S.K. Paulson et al., J. Pharmacol. Expt. Therap. 297(2) 638-645 (2001).
11. B.R. Rohrs, Disso. Technol. 8(8), 1-5 (2001).
12. J.B. Dressman et al., Pharm. Res. 15(1) 11-22 (1998).
13. J.R. Crison, N.D. Weiner and G.L. Amidon,J. Pharm. Sci. 86(3) 384-388 (1997).
14. V.P. Shah et al., Pharm. Res. 6(7) 612-618 (1989).
15. P. Costa and J.M.S. Lobo, Eur. J. Pharm. Sci. 13(2) 123-133 (2001).
16. T. Hara et al., Pharm. Sci. Tech. Today 1(5) (1998).